HCP Analysis in Biopharmaceuticals by Mass Spectrometry

Logo
Presented by

Annu Uppal PHD. at USP & Anita Krishnan at Biocon Biologics

About this talk

HCP Analysis in Biopharmaceuticals by Mass Spectrometry Best Practices for HCP Analysis in Biopharmaceuticals by Mass Spectrometry Presented by Annu Uppal PHD. Director-Scientific Affairs & Strategy at USP And Mass Spectrometry based Qualitative and Quantitative Profiling of HCP. Presented by Anita Krishnan, Head of Analytical Sciences at Biocon Biologics Mass spectrometry has become an increasingly common approach for identification and quantitation of Host cell proteins (HCPs) to support risk assessment and process development, as well as characterization and quality control. This presentation will provide an overview of the proposed general chapter <1132.1> Residual Host Cell Protein Measurement in Biopharmaceuticals by Mass Spectrometry. The best practices for instrument selection, sample preparation, LC separation, MS data acquisition, MS data analysis and reporting, with particular attention to the orthogonality of MS and traditional methods will be discussed. Additionally, there will be an update on the development of physical reference materials to support identification and quantitation of HCPs of particular concern.
Related topics:

More from this channel

Upcoming talks (40)
On-demand talks (352)
Subscribers (36506)
BioPharma Webinars aims to keep its global audience abreast of all developments in the areas of Drug Development, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality webinars, presented by the most respected people, working with companies in Pharmaceutical, Biopharmaceutical, Biologics and Biotech Industry.